NCT07441005

CompletedEarly Phase 1

Comparative Efficacy of Topical Oxiconazole Cream (1%) Versu...

Hayat Abad Medical Complex, Peshawar Source

Compare

Other study identifiers

Sponsor study identifier

HMCKPK Peshawar

Study Type

interventional

Actual enrollment (reported)

386

Locations

1 country

Sites

1

Timeline

Study Start

May 15, 2025

Actual (reported)

Primary Completion

October 15, 2025

Actual (reported)

Study Completion

October 15, 2025

Actual (reported)

Brief Summary

This study is conducted to compare the efficacy of topical oxiconazole 1% cream versus topical clotrimazole 1% cream in patients with tinea cruris.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 386 participants
Study completion date: October 15, 2025
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
May 15, 2025
Actual (reported)
Primary Completion
October 15, 2025
Actual (reported)
Study Completion
October 15, 2025
Actual (reported)
First Submitted
January 29, 2026
Actual (reported)
First Posted
February 27, 2026
Actual (reported)

Last Updated: February 27, 2026
Status Verified: February 2026
Last Update Submitted: February 25, 2026

Conditions

Tinea Cruris

Keywords

Tinea

Outcome Measures

Primary Outcomes (1)

Assessment of improvement i
Assessment of change in pruritis by VAS scoring. Assessment of change in erythema on VAS scoring. .
Six months

Study Arms (2)

Group A

ACTIVE COMPARATOR

Topical Oxiconazole (1%)

Drug: Topical Oxiconazole cream

Group B

ACTIVE COMPARATOR

Topical Clotrimazole (1%)

Drug: Topical Clotrimazole cream

Interventions

Topical Oxiconazole creamDrug

Group A will recieve topical Oxiconazole

Group A

Topical Clotrimazole creamDrug

Group B will recieve topical clotrimazole

Group B

Eligibility Criteria

Age18 Years - 70 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

to 70 years of age
Both genders

Sponsors & Collaborators

Hayat Abad Medical Complex, Peshawar
Governmentlead

Study Sites (1)

Hayatabad medal Complex

Peshawar, KPK, 0000, Pakistan

MeSH Terms

Conditions

Tinea CrurisTinea

Condition Hierarchy (Ancestors)

DermatomycosesMycosesBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousIntertrigoDermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, Eczematous

Study Officials

Dr Fahad Khan
MTI HMC KPK PESHAWAR
PRINCIPAL INVESTIGATOR

Enrollment

386 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: early phase 1
Allocation: RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER GOV
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Traine Medical Officer

Study Record Dates

First Submitted

January 29, 2026

First Posted

February 27, 2026

Study Start

May 15, 2025

Actual (reported)

NCT07718685

Comparative Study of Topical Oxiconazole 1% Cream Versus Clotrimazole 1% Cream in the Treatment of Dermatophytosis

Not ApplicableCompleted

NCT01105013

Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections

Phase 3Unknown

NCT05363449

Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Phase 1Completed

NCT07312604

A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis

Not ApplicableRecruiting

NCT07535424

Comparative Efficacy of Topical Clotrimazole Versus 2% Salicylic Acid in Otomycosis

Not ApplicableCompleted

NCT02394340

Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris

Phase 4Completed

Patient with diagnosis of tinea crurus as per operational definition

You may not qualify if:

Hypersensitivity to clotrimazole or Oxiconazole
Uncontrolled diabetes
Immunosuppresion
Patient with contact dermatitis

Contact the study team to confirm eligibility.

Primary Completion

October 15, 2025

Actual (reported)

Study Completion

October 15, 2025

Actual (reported)

Last Updated

February 27, 2026

Record last verified: 2026-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT07441005
Data provider: ClinicalTrials.gov
Source updated: 2026-02-27
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:37:31 UTC

Locations

PK(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Group A

Group B

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations